HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donna MacKinnon-Cameron Selected Research

Recombinant Proteins

1/2020Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donna MacKinnon-Cameron Research Topics

Disease

11Human Influenza (Influenza)
11/2022 - 01/2012
4Pneumococcal Infections
01/2022 - 01/2017
3Pneumonia (Pneumonitis)
01/2022 - 01/2019
3Tetanus
01/2018 - 03/2010
3Diphtheria
01/2018 - 03/2010
3Whooping Cough (Pertussis)
01/2018 - 03/2010
2Chronic Obstructive Pulmonary Disease (COPD)
11/2022 - 01/2019
2Frailty
06/2022 - 01/2017
1Virus Diseases (Viral Diseases)
11/2022
1COVID-19
01/2022
1Pharyngitis (Sore Throat)
01/2020
1Lyme Disease (Disease, Lyme)
01/2020
1Critical Illness (Critically Ill)
01/2019
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2018
1Respiratory Syncytial Virus Infections
01/2018
1Vesicular Stomatitis
06/2017
1Rotavirus Infections
01/2016
1Febrile Seizures (Febrile Seizure)
05/2012
1Cross Infection (Nosocomial Infection)
03/2009
1Infections
03/2009

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
01/2020 - 03/2010
5Influenza Vaccines (Influenza Vaccine)FDA Link
12/2018 - 05/2012
3Pertussis VaccineIBA
01/2018 - 03/2010
2AntigensIBA
01/2022 - 07/2020
2protein C activator peptideIBA
01/2022 - 01/2020
2Conjugate VaccinesIBA
01/2020 - 01/2019
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Granzymes (Granzyme)IBA
07/2020
1Interferon-gamma (Interferon, gamma)IBA
07/2020
1Influenza A virus NP proteinIBA
07/2020
1Peptides (Polypeptides)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1EnzymesIBA
01/2020
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Recombinant ProteinsIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2017
1Glycoproteins (Glycoprotein)IBA
06/2017

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
11/2022 - 12/2018
2Length of Stay
06/2022 - 01/2018
1Therapeutics
11/2022
1Noninvasive Ventilation
11/2022
1Long-Term Care
01/2019
1Cerebrospinal Fluid Shunts
03/2009